Innokas Medical Business Blog

Recent Posts

Co-creation and standardized working methods bring agility to the regulated MedTech world

MedTech as business is changing and getting more complex. For example, the technical complexity and regulatory requirements are something that are increasing as we speak. At the same time there is...

How to choose the right co-creation partner to save both time and money when designing and developing medical devices?

MedTech business is changing and getting more diverse. The technical complexity, caused mainly by digitization, is increasing. New technologies are being introduced at faster pace, the impact of...

Sales has started for Otivio’s FlowOx 2.0 device

FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, has now reached a significant milestone as the device has received CE mark and the sales has started....

How to shorten the medical device development cycle in practice?

MedTech business is changing and getting more diverse. The technical complexity, different forms of digitalization and related regulatory requirements are increasing as we speak. And there is the...

Cubist digitalizes the healthcare of tomorrow

Serres Group and Innokas Medical continue to strengthen their co-creation strategy and position in Scandinavia when Serres Group launches a new cooperation company in Sweden. Cubist IT AB is...

Health Business Breakfast – How to co-create next generation medical devices in an agile way?

Innokas Medical, Olfactomics and BusinessOulu/OuluHealth are arranging Health Business Breakfast event in Oulu in the beginning of November. Welcome to listen, discuss and network with the...

Competitiveness can be built by improving quality and regulatory management in medical device design and development

Before introducing new medical devices to the market, there’s much more than simply coming up with an innovative idea, building it, and offering it to the masses. One clear rule in the medical...

Olfactomics works for better equality in healthcare

An innovation developed by Finnish startup company Olfactomics helps to improve the accuracy of cancer surgeries by allowing rapid, real-time analysis of biological gas mixtures during the...

Co-creation and standardized working methods bring agility to the regulated MedTech world

MedTech as a business is changing and getting more complex. For example, the technical complexity and regulatory requirements are something that are increasing as we speak. At the same time there...

A long-term co-creation partnership as a common goal for GrainSense and Innokas Medical

Innokas Medical entered into cooperation agreement with Finnish company GrainSense Oy in 2016. The mutual interest for the companies is to develop a long-term, fruitful co-creation partnership,...

1 2 3
how to ensure the quality compliance of your medical product

Recent Posts

Subscribe to our newsletter